Holding(s) in Company

Dechra Pharmaceuticals PLC

05 January 2024

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

02-Jan-2024

6. Date on which Issuer notified

04-Jan-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	4.204432	2.765637	6.970069	7939360
Position of previous notification (if applicable)	4.248708	2.764113	7.012821

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		4789111		4.204432
Sub Total 8.A	4789111		4.204432%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	20/02/2024	20/02/2024	Cash	6220	0.005451
Cash-settled Equity Swap	04/03/2024	04/03/2024	Cash	5090	0.004468
Cash-settled Equity Swap	05/06/2024	05/06/2024	Cash	1420344	1.246945
Cash-settled Equity Swap	27/06/2024	27/06/2024	Cash	1169	0.001026
Cash-settled Equity Swap	12/07/2024	12/07/2024	Cash	1390089	1.220383
Cash-settled Equity Swap	31/07/2024	31/07/2024	Cash	39012	0.034249
Cash-settled Equity Swap	17/10/2024	17/10/2024	Cash	68288	0.059951
Cash-settled Equity Swap	04/11/2024	04/11/2024	Cash	17	0.000014
Cash-settled Equity Swap	20/11/2024	20/11/2024	Cash	2468	0.002166
Cash-settled Equity Swap	27/12/2024	27/12/2024	Cash	4037	0.003542
Cash-settled Equity Swap	22/01/2025	22/01/2025	Cash	202956	0.178178
Cash-settled Equity Swap	04/02/2025	04/02/2025	Cash	1603	0.001405
Cash-settled Equity Swap	05/02/2025	05/02/2025	Cash	1640	0.001438
Cash-settled Equity Swap	16/01/2026	16/01/2026	Cash	420	0.000368
Cash-settled Equity Swap	18/06/2027	18/06/2027	Cash	6891	0.006049
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	5	0.000004
Sub Total 8.B2				3150249	2.765637%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	4.164836		6.930473%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)

12. Date of Completion

04-Jan-2024

13. Place Of Completion

London, United Kingdom

 

END